nodes	percent_of_prediction	percent_of_DWPC	metapath
Flucytosine—Bone marrow toxicity—Cisplatin—bone cancer	0.198	0.212	CcSEcCtD
Flucytosine—Ventricular dysfunction—Epirubicin—bone cancer	0.0634	0.0682	CcSEcCtD
Flucytosine—Ventricular dysfunction—Doxorubicin—bone cancer	0.0587	0.0631	CcSEcCtD
Flucytosine—Liver injury—Cisplatin—bone cancer	0.0169	0.0182	CcSEcCtD
Flucytosine—Hearing impaired—Cisplatin—bone cancer	0.015	0.0161	CcSEcCtD
Flucytosine—Azotaemia—Methotrexate—bone cancer	0.0147	0.0158	CcSEcCtD
Flucytosine—Body temperature increased—Carboplatin—bone cancer	0.0137	0.0147	CcSEcCtD
Flucytosine—DNMT1—One Carbon Metabolism—DHFR—bone cancer	0.0132	0.188	CbGpPWpGaD
Flucytosine—DNMT1—Trans-sulfuration and one carbon metabolism—DHFR—bone cancer	0.0118	0.169	CbGpPWpGaD
Flucytosine—Deafness—Cisplatin—bone cancer	0.0116	0.0124	CcSEcCtD
Flucytosine—Gastrointestinal haemorrhage—Cisplatin—bone cancer	0.0103	0.0111	CcSEcCtD
Flucytosine—Hypokalaemia—Cisplatin—bone cancer	0.0094	0.0101	CcSEcCtD
Flucytosine—Liver injury—Epirubicin—bone cancer	0.00869	0.00934	CcSEcCtD
Flucytosine—Pancytopenia—Cisplatin—bone cancer	0.00848	0.00912	CcSEcCtD
Flucytosine—Liver injury—Doxorubicin—bone cancer	0.00804	0.00864	CcSEcCtD
Flucytosine—Renal failure—Cisplatin—bone cancer	0.00783	0.00842	CcSEcCtD
Flucytosine—Neuropathy peripheral—Cisplatin—bone cancer	0.00781	0.00839	CcSEcCtD
Flucytosine—Aplastic anaemia—Methotrexate—bone cancer	0.00733	0.00789	CcSEcCtD
Flucytosine—Aplastic anaemia—Epirubicin—bone cancer	0.00686	0.00738	CcSEcCtD
Flucytosine—Photosensitivity—Methotrexate—bone cancer	0.00646	0.00694	CcSEcCtD
Flucytosine—Aplastic anaemia—Doxorubicin—bone cancer	0.00635	0.00683	CcSEcCtD
Flucytosine—Hepatic function abnormal—Epirubicin—bone cancer	0.00607	0.00653	CcSEcCtD
Flucytosine—Photosensitivity—Epirubicin—bone cancer	0.00604	0.0065	CcSEcCtD
Flucytosine—DNMT1—PRC2 methylates histones and DNA—EZH2—bone cancer	0.00589	0.0842	CbGpPWpGaD
Flucytosine—Anaemia—Cisplatin—bone cancer	0.00575	0.00618	CcSEcCtD
Flucytosine—Hepatic function abnormal—Doxorubicin—bone cancer	0.00562	0.00604	CcSEcCtD
Flucytosine—Photosensitivity—Doxorubicin—bone cancer	0.00559	0.00601	CcSEcCtD
Flucytosine—Leukopenia—Cisplatin—bone cancer	0.00557	0.00599	CcSEcCtD
Flucytosine—Hypoglycaemia—Epirubicin—bone cancer	0.00544	0.00585	CcSEcCtD
Flucytosine—Convulsion—Cisplatin—bone cancer	0.00539	0.0058	CcSEcCtD
Flucytosine—Ataxia—Methotrexate—bone cancer	0.00533	0.00573	CcSEcCtD
Flucytosine—DNMT1—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.00532	0.076	CbGpPWpGaD
Flucytosine—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.00531	0.00571	CcSEcCtD
Flucytosine—Toxic epidermal necrolysis—Methotrexate—bone cancer	0.00511	0.00549	CcSEcCtD
Flucytosine—Cardiac arrest—Epirubicin—bone cancer	0.00505	0.00542	CcSEcCtD
Flucytosine—Hypoglycaemia—Doxorubicin—bone cancer	0.00503	0.00541	CcSEcCtD
Flucytosine—Ataxia—Epirubicin—bone cancer	0.00499	0.00536	CcSEcCtD
Flucytosine—Thrombocytopenia—Cisplatin—bone cancer	0.00497	0.00535	CcSEcCtD
Flucytosine—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.00491	0.00528	CcSEcCtD
Flucytosine—Eosinophilia—Methotrexate—bone cancer	0.00485	0.00522	CcSEcCtD
Flucytosine—Anorexia—Cisplatin—bone cancer	0.00484	0.0052	CcSEcCtD
Flucytosine—Hypokalaemia—Epirubicin—bone cancer	0.00483	0.00519	CcSEcCtD
Flucytosine—Toxic epidermal necrolysis—Epirubicin—bone cancer	0.00478	0.00514	CcSEcCtD
Flucytosine—Cardiac arrest—Doxorubicin—bone cancer	0.00467	0.00502	CcSEcCtD
Flucytosine—Pancytopenia—Methotrexate—bone cancer	0.00465	0.005	CcSEcCtD
Flucytosine—Ataxia—Doxorubicin—bone cancer	0.00462	0.00496	CcSEcCtD
Flucytosine—Paraesthesia—Cisplatin—bone cancer	0.00456	0.0049	CcSEcCtD
Flucytosine—Eosinophilia—Epirubicin—bone cancer	0.00454	0.00488	CcSEcCtD
Flucytosine—Dyspnoea—Cisplatin—bone cancer	0.00453	0.00487	CcSEcCtD
Flucytosine—Photosensitivity reaction—Methotrexate—bone cancer	0.00447	0.00481	CcSEcCtD
Flucytosine—Hypokalaemia—Doxorubicin—bone cancer	0.00447	0.0048	CcSEcCtD
Flucytosine—Toxic epidermal necrolysis—Doxorubicin—bone cancer	0.00442	0.00475	CcSEcCtD
Flucytosine—Decreased appetite—Cisplatin—bone cancer	0.00441	0.00475	CcSEcCtD
Flucytosine—Pancytopenia—Epirubicin—bone cancer	0.00436	0.00468	CcSEcCtD
Flucytosine—Renal failure—Methotrexate—bone cancer	0.0043	0.00462	CcSEcCtD
Flucytosine—Eosinophilia—Doxorubicin—bone cancer	0.0042	0.00452	CcSEcCtD
Flucytosine—Photosensitivity reaction—Epirubicin—bone cancer	0.00419	0.0045	CcSEcCtD
Flucytosine—Feeling abnormal—Cisplatin—bone cancer	0.00418	0.0045	CcSEcCtD
Flucytosine—Agranulocytosis—Methotrexate—bone cancer	0.00408	0.00438	CcSEcCtD
Flucytosine—Pancytopenia—Doxorubicin—bone cancer	0.00403	0.00433	CcSEcCtD
Flucytosine—Renal failure—Epirubicin—bone cancer	0.00402	0.00432	CcSEcCtD
Flucytosine—Body temperature increased—Cisplatin—bone cancer	0.00401	0.00432	CcSEcCtD
Flucytosine—Neuropathy peripheral—Epirubicin—bone cancer	0.00401	0.00431	CcSEcCtD
Flucytosine—Jaundice—Epirubicin—bone cancer	0.00399	0.00429	CcSEcCtD
Flucytosine—Haemoglobin—Methotrexate—bone cancer	0.00394	0.00424	CcSEcCtD
Flucytosine—Hepatitis—Methotrexate—bone cancer	0.00392	0.00422	CcSEcCtD
Flucytosine—Haemorrhage—Methotrexate—bone cancer	0.00392	0.00422	CcSEcCtD
Flucytosine—Photosensitivity reaction—Doxorubicin—bone cancer	0.00387	0.00416	CcSEcCtD
Flucytosine—Agranulocytosis—Epirubicin—bone cancer	0.00382	0.0041	CcSEcCtD
Flucytosine—DNMT1—Epigenetic regulation of gene expression—EZH2—bone cancer	0.00378	0.054	CbGpPWpGaD
Flucytosine—Hypersensitivity—Cisplatin—bone cancer	0.00374	0.00402	CcSEcCtD
Flucytosine—Renal failure—Doxorubicin—bone cancer	0.00372	0.004	CcSEcCtD
Flucytosine—Neuropathy peripheral—Doxorubicin—bone cancer	0.00371	0.00399	CcSEcCtD
Flucytosine—Haemoglobin—Epirubicin—bone cancer	0.00369	0.00397	CcSEcCtD
Flucytosine—Jaundice—Doxorubicin—bone cancer	0.00369	0.00397	CcSEcCtD
Flucytosine—Hepatitis—Epirubicin—bone cancer	0.00367	0.00395	CcSEcCtD
Flucytosine—Haemorrhage—Epirubicin—bone cancer	0.00367	0.00395	CcSEcCtD
Flucytosine—Asthenia—Cisplatin—bone cancer	0.00364	0.00392	CcSEcCtD
Flucytosine—Agranulocytosis—Doxorubicin—bone cancer	0.00353	0.0038	CcSEcCtD
Flucytosine—DNMT1—Regulation of retinoblastoma protein—CDK4—bone cancer	0.00348	0.0498	CbGpPWpGaD
Flucytosine—DNMT1—Regulation of retinoblastoma protein—MET—bone cancer	0.00348	0.0498	CbGpPWpGaD
Flucytosine—Diarrhoea—Cisplatin—bone cancer	0.00347	0.00374	CcSEcCtD
Flucytosine—Haemoglobin—Doxorubicin—bone cancer	0.00341	0.00367	CcSEcCtD
Flucytosine—Haemorrhage—Doxorubicin—bone cancer	0.0034	0.00365	CcSEcCtD
Flucytosine—Hepatitis—Doxorubicin—bone cancer	0.0034	0.00365	CcSEcCtD
Flucytosine—Vomiting—Cisplatin—bone cancer	0.00323	0.00347	CcSEcCtD
Flucytosine—Rash—Cisplatin—bone cancer	0.0032	0.00344	CcSEcCtD
Flucytosine—Dermatitis—Cisplatin—bone cancer	0.0032	0.00344	CcSEcCtD
Flucytosine—Anaemia—Methotrexate—bone cancer	0.00316	0.00339	CcSEcCtD
Flucytosine—Vertigo—Methotrexate—bone cancer	0.00307	0.0033	CcSEcCtD
Flucytosine—Leukopenia—Methotrexate—bone cancer	0.00306	0.00329	CcSEcCtD
Flucytosine—DNMT1—Regulation of retinoblastoma protein—RB1—bone cancer	0.00303	0.0433	CbGpPWpGaD
Flucytosine—Nausea—Cisplatin—bone cancer	0.00302	0.00324	CcSEcCtD
Flucytosine—Convulsion—Methotrexate—bone cancer	0.00296	0.00318	CcSEcCtD
Flucytosine—Anaemia—Epirubicin—bone cancer	0.00295	0.00318	CcSEcCtD
Flucytosine—Chest pain—Methotrexate—bone cancer	0.00291	0.00313	CcSEcCtD
Flucytosine—DNMT1—Gene Expression—ZNF77—bone cancer	0.0029	0.0415	CbGpPWpGaD
Flucytosine—Vertigo—Epirubicin—bone cancer	0.00287	0.00309	CcSEcCtD
Flucytosine—Leukopenia—Epirubicin—bone cancer	0.00286	0.00308	CcSEcCtD
Flucytosine—Confusional state—Methotrexate—bone cancer	0.00281	0.00302	CcSEcCtD
Flucytosine—DNMT1—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.00279	0.0399	CbGpPWpGaD
Flucytosine—Convulsion—Epirubicin—bone cancer	0.00277	0.00298	CcSEcCtD
Flucytosine—Anaemia—Doxorubicin—bone cancer	0.00273	0.00294	CcSEcCtD
Flucytosine—Thrombocytopenia—Methotrexate—bone cancer	0.00273	0.00293	CcSEcCtD
Flucytosine—Chest pain—Epirubicin—bone cancer	0.00272	0.00293	CcSEcCtD
Flucytosine—Dry mouth—Epirubicin—bone cancer	0.00266	0.00286	CcSEcCtD
Flucytosine—Vertigo—Doxorubicin—bone cancer	0.00266	0.00286	CcSEcCtD
Flucytosine—Anorexia—Methotrexate—bone cancer	0.00266	0.00286	CcSEcCtD
Flucytosine—Leukopenia—Doxorubicin—bone cancer	0.00265	0.00285	CcSEcCtD
Flucytosine—Confusional state—Epirubicin—bone cancer	0.00263	0.00283	CcSEcCtD
Flucytosine—DNMT1—Regulation of retinoblastoma protein—MDM2—bone cancer	0.00258	0.0369	CbGpPWpGaD
Flucytosine—Convulsion—Doxorubicin—bone cancer	0.00256	0.00275	CcSEcCtD
Flucytosine—Thrombocytopenia—Epirubicin—bone cancer	0.00255	0.00275	CcSEcCtD
Flucytosine—Chest pain—Doxorubicin—bone cancer	0.00252	0.00271	CcSEcCtD
Flucytosine—Paraesthesia—Methotrexate—bone cancer	0.0025	0.00269	CcSEcCtD
Flucytosine—Anorexia—Epirubicin—bone cancer	0.00249	0.00267	CcSEcCtD
Flucytosine—Dyspnoea—Methotrexate—bone cancer	0.00248	0.00267	CcSEcCtD
Flucytosine—Dry mouth—Doxorubicin—bone cancer	0.00246	0.00265	CcSEcCtD
Flucytosine—Confusional state—Doxorubicin—bone cancer	0.00243	0.00262	CcSEcCtD
Flucytosine—DNMT1—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.00243	0.0347	CbGpPWpGaD
Flucytosine—Decreased appetite—Methotrexate—bone cancer	0.00242	0.0026	CcSEcCtD
Flucytosine—Fatigue—Methotrexate—bone cancer	0.0024	0.00258	CcSEcCtD
Flucytosine—Thrombocytopenia—Doxorubicin—bone cancer	0.00236	0.00254	CcSEcCtD
Flucytosine—Paraesthesia—Epirubicin—bone cancer	0.00234	0.00252	CcSEcCtD
Flucytosine—Dyspnoea—Epirubicin—bone cancer	0.00233	0.0025	CcSEcCtD
Flucytosine—Anorexia—Doxorubicin—bone cancer	0.0023	0.00247	CcSEcCtD
Flucytosine—Feeling abnormal—Methotrexate—bone cancer	0.0023	0.00247	CcSEcCtD
Flucytosine—Gastrointestinal pain—Methotrexate—bone cancer	0.00228	0.00245	CcSEcCtD
Flucytosine—Decreased appetite—Epirubicin—bone cancer	0.00227	0.00244	CcSEcCtD
Flucytosine—Fatigue—Epirubicin—bone cancer	0.00225	0.00242	CcSEcCtD
Flucytosine—DNMT1—Regulation of retinoblastoma protein—JUN—bone cancer	0.00225	0.0321	CbGpPWpGaD
Flucytosine—Urticaria—Methotrexate—bone cancer	0.00221	0.00238	CcSEcCtD
Flucytosine—Body temperature increased—Methotrexate—bone cancer	0.0022	0.00237	CcSEcCtD
Flucytosine—Abdominal pain—Methotrexate—bone cancer	0.0022	0.00237	CcSEcCtD
Flucytosine—Paraesthesia—Doxorubicin—bone cancer	0.00217	0.00233	CcSEcCtD
Flucytosine—Dyspnoea—Doxorubicin—bone cancer	0.00215	0.00231	CcSEcCtD
Flucytosine—Feeling abnormal—Epirubicin—bone cancer	0.00215	0.00231	CcSEcCtD
Flucytosine—Gastrointestinal pain—Epirubicin—bone cancer	0.00213	0.00229	CcSEcCtD
Flucytosine—Decreased appetite—Doxorubicin—bone cancer	0.0021	0.00226	CcSEcCtD
Flucytosine—Fatigue—Doxorubicin—bone cancer	0.00208	0.00224	CcSEcCtD
Flucytosine—Urticaria—Epirubicin—bone cancer	0.00207	0.00223	CcSEcCtD
Flucytosine—DNMT1—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.00207	0.0296	CbGpPWpGaD
Flucytosine—Abdominal pain—Epirubicin—bone cancer	0.00206	0.00222	CcSEcCtD
Flucytosine—Body temperature increased—Epirubicin—bone cancer	0.00206	0.00222	CcSEcCtD
Flucytosine—Hypersensitivity—Methotrexate—bone cancer	0.00205	0.00221	CcSEcCtD
Flucytosine—Asthenia—Methotrexate—bone cancer	0.002	0.00215	CcSEcCtD
Flucytosine—Feeling abnormal—Doxorubicin—bone cancer	0.00199	0.00214	CcSEcCtD
Flucytosine—Gastrointestinal pain—Doxorubicin—bone cancer	0.00197	0.00212	CcSEcCtD
Flucytosine—Pruritus—Methotrexate—bone cancer	0.00197	0.00212	CcSEcCtD
Flucytosine—Hypersensitivity—Epirubicin—bone cancer	0.00192	0.00207	CcSEcCtD
Flucytosine—Urticaria—Doxorubicin—bone cancer	0.00192	0.00206	CcSEcCtD
Flucytosine—Body temperature increased—Doxorubicin—bone cancer	0.00191	0.00205	CcSEcCtD
Flucytosine—Abdominal pain—Doxorubicin—bone cancer	0.00191	0.00205	CcSEcCtD
Flucytosine—Diarrhoea—Methotrexate—bone cancer	0.00191	0.00205	CcSEcCtD
Flucytosine—Asthenia—Epirubicin—bone cancer	0.00187	0.00201	CcSEcCtD
Flucytosine—Pruritus—Epirubicin—bone cancer	0.00185	0.00198	CcSEcCtD
Flucytosine—Diarrhoea—Epirubicin—bone cancer	0.00178	0.00192	CcSEcCtD
Flucytosine—Hypersensitivity—Doxorubicin—bone cancer	0.00178	0.00191	CcSEcCtD
Flucytosine—Vomiting—Methotrexate—bone cancer	0.00177	0.00191	CcSEcCtD
Flucytosine—Rash—Methotrexate—bone cancer	0.00176	0.00189	CcSEcCtD
Flucytosine—Dermatitis—Methotrexate—bone cancer	0.00176	0.00189	CcSEcCtD
Flucytosine—Headache—Methotrexate—bone cancer	0.00175	0.00188	CcSEcCtD
Flucytosine—Asthenia—Doxorubicin—bone cancer	0.00173	0.00186	CcSEcCtD
Flucytosine—Pruritus—Doxorubicin—bone cancer	0.00171	0.00184	CcSEcCtD
Flucytosine—Vomiting—Epirubicin—bone cancer	0.00166	0.00178	CcSEcCtD
Flucytosine—Nausea—Methotrexate—bone cancer	0.00166	0.00178	CcSEcCtD
Flucytosine—Diarrhoea—Doxorubicin—bone cancer	0.00165	0.00178	CcSEcCtD
Flucytosine—Rash—Epirubicin—bone cancer	0.00164	0.00177	CcSEcCtD
Flucytosine—Dermatitis—Epirubicin—bone cancer	0.00164	0.00177	CcSEcCtD
Flucytosine—Headache—Epirubicin—bone cancer	0.00163	0.00176	CcSEcCtD
Flucytosine—Nausea—Epirubicin—bone cancer	0.00155	0.00167	CcSEcCtD
Flucytosine—Vomiting—Doxorubicin—bone cancer	0.00153	0.00165	CcSEcCtD
Flucytosine—Rash—Doxorubicin—bone cancer	0.00152	0.00164	CcSEcCtD
Flucytosine—Dermatitis—Doxorubicin—bone cancer	0.00152	0.00163	CcSEcCtD
Flucytosine—Headache—Doxorubicin—bone cancer	0.00151	0.00163	CcSEcCtD
Flucytosine—Nausea—Doxorubicin—bone cancer	0.00143	0.00154	CcSEcCtD
Flucytosine—DNMT1—Gene Expression—FUS—bone cancer	0.00142	0.0203	CbGpPWpGaD
Flucytosine—DNMT1—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.00119	0.017	CbGpPWpGaD
Flucytosine—DNMT1—Gene Expression—NR1I2—bone cancer	0.000983	0.0141	CbGpPWpGaD
Flucytosine—DNMT1—Gene Expression—EIF2S1—bone cancer	0.000726	0.0104	CbGpPWpGaD
Flucytosine—DNMT1—Gene Expression—EZH2—bone cancer	0.000631	0.00902	CbGpPWpGaD
